Two Sigma Advisers LP Purchases 120,600 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Two Sigma Advisers LP boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4,824.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 123,100 shares of the medical equipment provider's stock after acquiring an additional 120,600 shares during the period. Two Sigma Advisers LP's holdings in Intuitive Surgical were worth $64,253,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in ISRG. Atala Financial Inc bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $25,000. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $26,000. Parvin Asset Management LLC bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $26,000. BankPlus Trust Department bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Hurley Capital LLC bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Trading Down 0.8%

Shares of NASDAQ ISRG traded down $4.40 during mid-day trading on Thursday, hitting $542.67. The company had a trading volume of 1,128,016 shares, compared to its average volume of 1,644,782. The company has a market capitalization of $194.50 billion, a price-to-earnings ratio of 84.66, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 1 year low of $396.15 and a 1 year high of $616.00. The stock's 50-day moving average price is $510.44 and its 200-day moving average price is $537.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter last year, the company earned $1.50 earnings per share. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 2,401 shares of Intuitive Surgical stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the completion of the sale, the executive vice president now owns 353 shares of the company's stock, valued at approximately $205,093. This trade represents a 87.18% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares of the company's stock, valued at $2,607,925.28. This represents a 68.85% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 32,700 shares of company stock valued at $16,865,621. Company insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the company. Barclays dropped their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Bernstein Bank increased their price target on Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research report on Monday, January 27th. Piper Sandler decreased their price target on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a research report on Wednesday, April 23rd. Wells Fargo & Company increased their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Finally, JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $596.05.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.